1. India Hypertension Control Initiative—Hypertension treatment and blood pressure control in a cohort in 24 sentinel site clinics
- Author
-
Kiran Durgad, Sravan Chenji, Abhishek Kunwar, Sadhana Tayade, Pooja Gaigaware, Prabhdeep Kaur, Tapas Chakma, Ganesh Parasuraman, Gurinder Bir Singh, Chakshu Joshi, R S Dhaliwal, Jhilam Mitra, Suniti Yadav, Vettrichelvan Venkatasamy, Rupali Bharadwaj, Sravan K Reddy, Sunil Dar, Pankaj Uike, Sampada Dipak Bangar, Fikru Tesfaye Tullu, Bidisha Das, Balram Bhargava, Sivasubramanian Ramakrishnan, Vidhya Viswanathan, Saurabh Purohit, Chintala Sreedhar, Leimapokpam Swasticharan, Raviteja Dharamsoth, Meenakshi Sharma, Savitha Kasiviswanathan, Chinmoyee Das, Suhas Khedkar, Sailaja Bitragunta, and Vishwajit Bharadwaj
- Subjects
Adult ,Blood pressure control ,medicine.medical_specialty ,noncommunicable diseases ,Endocrinology, Diabetes and Metabolism ,India ,Blood Pressure ,Population health ,030204 cardiovascular system & hematology ,hypertension control ,03 medical and health sciences ,0302 clinical medicine ,Internal Medicine ,Humans ,Medicine ,030212 general & internal medicine ,Medical prescription ,raised blood pressure ,Antihypertensive Agents ,Original Paper ,Primary Health Care ,Hypertension control ,business.industry ,Public health ,Original Papers ,Sentinel site ,Blood pressure ,Hypertension ,Cohort ,Emergency medicine ,Cardiology and Cardiovascular Medicine ,business - Abstract
The India Hypertension Control Initiative (IHCI) is a multi‐partner initiative, implementing and scaling up a public health hypertension control program across India. A cohort of 21,895 adult hypertension patients in 24 IHCI sentinel site facilities in four Indian states (Punjab, Madhya Pradesh, Maharashtra, and Telangana), registered from January 2018 until June 2019 were assessed at baseline and then followed up for blood pressure (BP) control and antihypertensive medication use. Among all registrations, 11 274 (51%) of the patients returned for a follow‐up visit between July 2019 and September 2019. Among patients returning for follow‐up, 26.3% had BP controlled at registration, and 59.8% had BP controlled at follow‐up (p
- Published
- 2020